CRMD - CorMedix - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CRMD is currently covered by 5 analysts with an average price target of $17.63. This is a potential upside of $6.51 (58.54%) from yesterday's end of day stock price of $11.12.

CorMedix's activity chart (see below) currently has 37 price targets and 52 ratings on display. The stock rating distribution of CRMD is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 54.46% with an average time for these price targets to be met of 431.13 days.

Highest price target for CRMD is $22, Lowest price target is $12, average price target is $18.

Most recent stock forecast was given by JASON BUTLER from JMP on 09-Sep-2025. First documented stock forecast 12-Dec-2018.

Currently out of the existing stock ratings of CRMD, 26 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$22

$9.06 (70.02%)

$19

8 days ago
(09-Sep-2025)

2/10 (20%)

$8.97 (68.84%)

925

Buy

$15

2 months 18 days ago
(30-Jun-2025)

7/7 (100%)

$-1.56 (-9.42%)

92

Buy

$20

$7.06 (54.56%)

$15

2 months 24 days ago
(24-Jun-2025)

14/17 (82.35%)

$4.28 (27.23%)

353

Buy

$12

$-0.94 (-7.26%)

$12

5 months 22 days ago
(26-Mar-2025)

5/5 (100%)

$4.84 (67.60%)

171

Buy

1 years 10 months 3 days ago
(15-Nov-2023)

0/1 (0%)

$8.28 (70.65%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CRMD (CorMedix) average time for price targets to be met?

On average it took 431.13 days on average for the stock forecasts to be realized with a an average price target met ratio 54.46

Which analyst has the current highest performing score on CRMD (CorMedix) with a proven track record?

JASON BUTLER

Which analyst has the current lower performing score on CRMD (CorMedix) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the most public recommendations on CRMD (CorMedix)?

Jason Butler works at JMP and has 5 price targets and 3 ratings on CRMD

Which analyst is the currently most bullish on CRMD (CorMedix)?

Andrew D'silva with highest potential upside - $20.02

Which analyst is the currently most reserved on CRMD (CorMedix)?

Gregory Renza with lowest potential downside - -$0.94

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?